Latest Artal Group S.A. Stock Portfolio
$3.93Billion– No. of Holdings #107
Artal Group S.A. Performance:
2024 Q1: 7.2%YTD: 7.2%2023: 2.5%
Performance for 2024 Q1 is 7.2%, and YTD is 7.2%, and 2023 is 2.5%.
About Artal Group S.A. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Artal Group S.A. reported an equity portfolio of $3.9 Billions as of 31 Mar, 2024.
The top stock holdings of Artal Group S.A. are , LXRX, SRRK. The fund has invested 47.3% of it's portfolio in CAVA GROUP INC and 7.2% of portfolio in LEXICON PHARMACEUTICALS INC.
The fund managers got completely rid off ARGENX SE (ARGX), HARPOON THERAPEUTICS INC (HARP) and NATERA INC (NTRA) stocks. They significantly reduced their stock positions in ACHILLES THERAPEUTICS PLC (ACHL), CYTOKINETICS INC (CYTK) and VOR BIOPHARMA INC (VOR). Artal Group S.A. opened new stock positions in CRINETICS PHARMACEUTICALS INC (CRNX), MADRIGAL PHARMACEUTICALS INC (MDGL) and VERA THERAPEUTICS INC (VERA). The fund showed a lot of confidence in some stocks as they added substantially to ALPINE IMMUNE SCIENCES INC (ALPN), TOURMALINE BIO INC and ARROWHEAD PHARMACEUTICALS INC (ARWR).
The top stock holdings of Artal Group S.A. are , LXRX, SRRK. The fund has invested 47.3% of it's portfolio in CAVA GROUP INC and 7.2% of portfolio in LEXICON PHARMACEUTICALS INC.
The fund managers got completely rid off ARGENX SE (ARGX), HARPOON THERAPEUTICS INC (HARP) and NATERA INC (NTRA) stocks. They significantly reduced their stock positions in ACHILLES THERAPEUTICS PLC (ACHL), CYTOKINETICS INC (CYTK) and VOR BIOPHARMA INC (VOR). Artal Group S.A. opened new stock positions in CRINETICS PHARMACEUTICALS INC (CRNX), MADRIGAL PHARMACEUTICALS INC (MDGL) and VERA THERAPEUTICS INC (VERA). The fund showed a lot of confidence in some stocks as they added substantially to ALPINE IMMUNE SCIENCES INC (ALPN), TOURMALINE BIO INC and ARROWHEAD PHARMACEUTICALS INC (ARWR).
Artal Group S.A. Equity Portfolio Value
Last Reported on: 17 May, 2024
Artal Group S.A. Annual Return Estimates Vs S&P 500
Our best estimate is that Artal Group S.A. made a return of 7.2% in the last quarter. In trailing 12 months, it's portfolio return was 13.15%.
New Buys
| Ticker | $ Bought |
|---|---|
| crinetics pharmaceuticals inc | 65,088,200 |
| madrigal pharmaceuticals inc | 29,509,800 |
| vera therapeutics inc | 21,819,500 |
| viking therapeutics inc | 20,816,800 |
| merus n v | 20,492,300 |
| newamsterdam pharma company | 18,920,000 |
| tango therapeutics inc | 17,427,000 |
| edgewise therapeutics inc | 14,805,700 |
New stocks bought by Artal Group S.A.
Additions
| Ticker | % Inc. |
|---|---|
| alpine immune sciences inc | 699 |
| tourmaline bio inc | 243 |
| arrowhead pharmaceuticals inc | 195 |
| solid biosciences inc | 174 |
| mongodb inc | 100 |
| paypal hldgs inc | 100 |
| prothena corp plc | 99.73 |
| advanced micro devices inc | 80.00 |
Additions to existing portfolio by Artal Group S.A.
Reductions
| Ticker | % Reduced |
|---|---|
| achilles therapeutics plc | -66.51 |
| cytokinetics inc | -58.28 |
| vor biopharma inc | -57.4 |
| taiwan semiconductor mfg ltd | -52.94 |
| amicus therapeutics inc | -50.07 |
| black diamond therapeutics inc | -48.86 |
| denali therapeutics inc | -37.36 |
| sea ltd | -36.16 |
Artal Group S.A. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| harpoon therapeutics inc | -14,828,000 |
| fusion pharmaceuticals inc | -9,663,000 |
| roivant sciences ltd | -11,230,000 |
| ikena oncology inc | -1,969,000 |
| 23andme holding co | -604,000 |
| replimune group inc | -4,215,000 |
| xilio therapeutics inc | -248,000 |
| iteos therapeutics inc | -4,380,000 |
Artal Group S.A. got rid off the above stocks
Sector Distribution
Artal Group S.A. has about 54.6% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 54.6 |
| Healthcare | 44.9 |
Market Cap. Distribution
Artal Group S.A. has about 1.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 54.6 |
| SMALL-CAP | 24.4 |
| MID-CAP | 15.4 |
| MICRO-CAP | 2.6 |
| MEGA-CAP | 1.9 |
Stocks belong to which Index?
About 0% of the stocks held by Artal Group S.A. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 100 |
Artal Group S.A. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Artal Group S.A.
Artal Group S.A. has 107 stocks in it's portfolio. About 73.9% of the portfolio is in top 10 stocks. SRRK proved to be the most loss making stock for the portfolio. LXRX was the most profitable stock for Artal Group S.A. last quarter.
Last Reported on: 17 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AAPL | apple inc | 0.04 | 10,000 | 1,714,800 | new | |||
| ACHL | achilles therapeutics plc | 0.02 | 755,375 | 944,219 | reduced | -66.51 | ||
| ADAG | adagene inc | 0.07 | 1,020,000 | 2,856,000 | added | 2.00 | ||
| ADBE | adobe inc | 0.04 | 3,100 | 1,564,260 | new | |||
| AGEN | agenus inc | 0.23 | 781,562 | 9,066,120 | unchanged | 0.00 | ||
| ALPN | alpine immune sciences inc | 0.41 | 405,784 | 16,085,300 | added | 699 | ||
| ALVR | allovir inc | 0.13 | 6,597,170 | 4,980,200 | unchanged | 0.00 | ||
| AMD | advanced micro devices inc | 0.02 | 4,500 | 812,205 | added | 80.00 | ||
| AMZN | amazon com inc | 0.06 | 12,000 | 2,164,560 | unchanged | 0.00 | ||
| APLS | apellis pharmaceuticals inc | 1.97 | 1,315,280 | 77,312,300 | reduced | -7.46 | ||
| APLT | applied therapeutics inc | 0.17 | 1,009,500 | 6,864,600 | new | |||
| ARGX | argenx se | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARWR | arrowhead pharmaceuticals inc | 2.21 | 3,036,670 | 86,848,700 | added | 195 | ||
| ATXS | astria therapeutics inc | 0.32 | 884,214 | 12,445,300 | new | |||
| AXSM | axsome therapeutics inc | 0.16 | 76,837 | 6,131,590 | new | |||
| BDTX | black diamond therapeutics inc | 0.14 | 1,046,520 | 5,305,840 | reduced | -48.86 | ||
| BEKE | ke holdings inc | 0.10 | 275,000 | 3,775,750 | added | 10.00 | ||
| BGNE | beigene ltd | 1.61 | 404,782 | 63,303,900 | added | 0.07 | ||
| BZ | kanzhun limited | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CBAY | cymabay therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||